MD732Y - Method for determining the maximum speech intelligibility index - Google Patents

Method for determining the maximum speech intelligibility index Download PDF

Info

Publication number
MD732Y
MD732Y MDS20130066A MDS20130066A MD732Y MD 732 Y MD732 Y MD 732Y MD S20130066 A MDS20130066 A MD S20130066A MD S20130066 A MDS20130066 A MD S20130066A MD 732 Y MD732 Y MD 732Y
Authority
MD
Moldova
Prior art keywords
speech intelligibility
determining
index
maximum speech
intelligibility index
Prior art date
Application number
MDS20130066A
Other languages
Moldavian (mo)
Romanian (ro)
Inventor
Sergiu Parii
Constantin Jucovschi
Original Assignee
Univ Nicolae Testemitanu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nicolae Testemitanu filed Critical Univ Nicolae Testemitanu
Priority to MDS20130066A priority Critical patent/MD732Z/en
Publication of MD732Y publication Critical patent/MD732Y/en
Publication of MD732Z publication Critical patent/MD732Z/en

Links

Landscapes

  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

The invention relates to medicine, in particular to otorhinolaryngology and can be used for estimating the speech intelligibility.Summary of the method consists in that it is carried out the tonal audiometric study with the definition of the following parameters: auditory threshold mean (PA), discomfort threshold mean (PD), audiometric curve type (CA), articulation index (IA), deafness degree mean (GS), then on the basis of the obtained results is calculated the maximum speech intelligibility index (y), according to the formula:y = 0.784xPA + 0.230xPD - 1.192xCA - 0.214xIA - 0.590xGS +51.055.
MDS20130066A 2013-04-12 2013-04-12 Method for determining the maximum speech intelligibility index MD732Z (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20130066A MD732Z (en) 2013-04-12 2013-04-12 Method for determining the maximum speech intelligibility index

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20130066A MD732Z (en) 2013-04-12 2013-04-12 Method for determining the maximum speech intelligibility index

Publications (2)

Publication Number Publication Date
MD732Y true MD732Y (en) 2014-02-28
MD732Z MD732Z (en) 2014-09-30

Family

ID=50231652

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20130066A MD732Z (en) 2013-04-12 2013-04-12 Method for determining the maximum speech intelligibility index

Country Status (1)

Country Link
MD (1) MD732Z (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD1039C2 (en) * 1997-02-13 1999-06-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Diagnosis method of latent inflammatory affections of the midlle ear to children during their first year of life
MD1041C2 (en) * 1997-02-13 1999-06-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method for prognostication of middle ear latent diseases to children in the first year of life
MD291Z (en) * 2010-07-19 2011-07-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method for predicting the development of adverse effects in hearing aids
RU2467691C1 (en) * 2011-05-25 2012-11-27 Государственное образовательное учреждение высшего профессионального образования "Астраханская государственная медицинская академия" Министерства здравоохранения и социального развития Российской Федерации Diagnostic technique for hearing level
  • 2013

Also Published As

Publication number Publication date
MD732Z (en) 2014-09-30

Similar Documents

Publication Publication Date Title
MX2016000201A (en) Antibody formulations and methods.
SA517381828B1 (en) Compounds, Compositions, and Methods for Increasing CFTR Activity
MX2021007268A (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl] amino}acetic acid, compositions, and uses thereof.
EP3995086C0 (en) MEDICAL DEVICE FOR MODIFYING THE LEFT HEART EAR
EP2813175A3 (en) A hearing assistance device with brain-computer interface
WO2015143343A3 (en) Methods and compositions for treatment of immune-related diseases or disorders and/or therapy monitoring
CL2017002781A1 (en) Alzheimer's disease treatment methods
EP2981326A4 (en) Headset for treatment and assessment of medical conditions
BR112014030330A2 (en) ophthalmic lenses taking into account the wearer's laterality
WO2014115115A3 (en) Determining apnea-hypopnia index ahi from speech
MX2023007194A (en) Compositions, methods and systems for the treatment of cutaneous disorders.
MX354821B (en) Method and device for monitoring ophthalmic lens manufacturing conditions.
WO2015181251A3 (en) Apparatus and method for the prophylaxis of hearing impairment or vertigo
MX378321B (en) METHODS OF TRANSDIFFERENTIATION AND METHODS OF USING IT.
MY199801A (en) Use of collagen hydrolysate for improving endurance performance and for stimulating lipid catabolism
EP3218481A4 (en) Biomarkers useful in the treatment of subjects having diseases of the eye
ZA202002779B (en) Dantrolene prodrugs and methods of their use
MX2016007902A (en) Compositions and methods for treatment of glaucoma.
WO2015081073A3 (en) Compositions and methods for modulating an immune response
MX2019000677A (en) B-cell-mimetic cells.
TWD191352S (en) Wire stripper
MX2018000528A (en) Device for detecting misfolded proteins and methods of use therof.
GB201102108D0 (en) Diagnostic method
MX388050B (en) REDUCTION OF MINIMUM INHIBITORY CONCENTRATION (MIC) WITH LITHIUM IONS.
WO2016003096A3 (en) White noise generating headset for stress relaxation and concentration improvement, and white noise generating method using same

Legal Events

Date Code Title Description
FG9Y Short term patent issued
KA4Y Short-term patent lapsed due to non-payment of fees (with right of restoration)